ACTIVE

L-LPHARMA

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result128,6 k €+94,7 %over 1 year
Gross margin185 k €+58,0 %over 1 year
Equity593,6 k €+16,4 %over 1 year

Identity

Source · BCE/KBO

L-LPHARMA is a Private limited company incorporated in 2016. Its main activity is: Activities of holding companies. Its registered office is in Arendonk.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0666.963.585
Incorporation
05/12/2016
Legal form
Private limited company
Registered office
Vrijheid 71 box 5
2370 Arendonk · FlandreSee on map
Contributed capital
18 600,00 €
Latest accounts
31/12/2025
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 9 filings

Trend over 9 financial years

20252024202320222021
Income statement
Gross margin185 k €117,1 k €148,5 k €135,5 k €132,9 k €
EBITDA181,7 k €115 k €146,6 k €133,8 k €130,3 k €
Operating result175,7 k €109 k €140,7 k €127,9 k €124,9 k €
Net result128,6 k €66 k €100,6 k €89,8 k €87,1 k €
Balance sheet
Equity593,6 k €510 k €437,8 k €382,2 k €292,4 k €
Total assets1,3 M €1,3 M €1,3 M €1,4 M €1,3 M €
Cash6,1 k €5,5 k €11,1 k €5,3 k €17,1 k €
Debts724,6 k €751,6 k €871,5 k €968,4 k €1 M €

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Lynn Leemans

Director · since 05 décembre 2016

Active

Ended mandates

Lynn Leemans

Manager · since 05 décembre 2016

Ended

Other companies at this address

Vrijheid 71 2370 Arendonk
CompanyCBE no.
Apotheek De Vrijheid● Active
0426.025.384

Full financial information

Source · NBB
202520242023202220212020
Type of accountMicro modelMicro modelMicro modelMicro modelMicro modelMicro model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date01/07/202615/07/202526/07/202423/10/202310/10/202229/09/2021
General meeting22/06/202623/06/202526/07/202405/10/202320/06/202221/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for 7 days

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Micro model31/12/202522/06/202601/07/2026DutchPDF
Micro model31/12/202423/06/202515/07/2025DutchPDF
Micro model31/12/202326/07/202426/07/2024DutchPDF
Micro model31/12/202205/10/202323/10/2023DutchPDF
Micro model31/12/202120/06/202210/10/2022DutchPDF
Micro model31/12/202021/06/202129/09/2021DutchPDF
Micro model31/12/201922/06/202011/09/2020DutchPDF
Micro model31/12/201817/06/201930/08/2019DutchPDF
Micro model31/12/201718/06/201831/08/2018DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active · 1 ended

Active mandates

Lynn Leemans

Director · since 05 décembre 2016

Active

Ended mandates

Lynn Leemans

Manager · since 05 décembre 2016

Ended

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates14/12/2023
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Registered office06/03/2017
    MAATSCHAPPELIJKE ZETEL - ADRESSEN ANDERS DAN MAATSCHAPPELIJKE ZETEL
    PDF
  • Other07/12/2016
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025128,6 k €↑
  2. 2024
    Annual accounts 202466 k €↓
  3. 2023
    Annual accounts 2023100,6 k €↑
  4. 2022
    Annual accounts 202289,8 k €↑
  5. 2022
    Name changeL-L Pharma
  6. 2021
    Annual accounts 202187,1 k €↑
  7. 2020
    Annual accounts 202043,1 k €↓
  8. 2019
    Annual accounts 201954,3 k €↑
  9. 2018
    Annual accounts 201851,1 k €↑
  10. 2017
    Annual accounts 201744,4 k €
  11. 2017
    Name changeL-LPharma
  12. 05/12/2016
    IncorporationPrivate limited company